Literature DB >> 31054761

ACR Appropriateness Criteria® Clinically Suspected Adnexal Mass, No Acute Symptoms.

Mostafa Atri1, Abdullah Alabousi2, Caroline Reinhold3, Esma A Akin4, Carol B Benson5, Priyadarshani R Bhosale6, Stella K Kang7, Yulia Lakhman8, Refky Nicola9, Pari V Pandharipande10, Maitray D Patel11, Gloria M Salazar10, Thomas D Shipp12, Lynn Simpson13, Betsy L Sussman14, Jennifer W Uyeda5, Darci J Wall15, Bradford P Whitcomb16, Carolyn M Zelop17, Phyllis Glanc18.   

Abstract

There are approximately 9.1 pelvic surgeries performed for every histologically confirmed adnexal malignancy in the United States, compared to 2.3 surgeries per malignancy (in oncology centers) and 5.9 surgeries per malignancy (in other centers) in Europe. An important prognostic factor in the long-term survival in patients with ovarian malignancy is the initial management by a gynecological oncologist. With high accuracy of imaging for adnexal mass characterization and consequent appropriate triage to subspecialty referral, the better use of gynecologic oncology can improve treatment outcomes. Ultrasound, including transabdominal, transvaginal, and duplex ultrasound, combined with MRI with contrast can diagnose adnexal masses as benign with specific features (ie, functional masses, dermoid, endometrioma, fibroma, pedunculated fibroid, hydrosalpinx, peritoneal inclusion cyst, Tarlov cyst), malignant, or indeterminate. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
Copyright © 2019 American College of Radiology. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AUC; Adnexal mass; Appropriate Use Criteria; Appropriateness Criteria; Asymptomatic; MRI; Postmenopausal; Premenopausal; Ultrasound

Mesh:

Substances:

Year:  2019        PMID: 31054761     DOI: 10.1016/j.jacr.2019.02.011

Source DB:  PubMed          Journal:  J Am Coll Radiol        ISSN: 1546-1440            Impact factor:   5.532


  4 in total

Review 1.  Mucinous Neoplasms of the Ovary: Radiologic-Pathologic Correlation.

Authors:  Jamie Marko; Kathryn I Marko; Suvidya L Pachigolla; Barbara A Crothers; Rubina Mattu; Darcy J Wolfman
Journal:  Radiographics       Date:  2019 Jul-Aug       Impact factor: 5.333

Review 2.  Current update on malignant epithelial ovarian tumors.

Authors:  Sherif B Elsherif; Priya R Bhosale; Chandana Lall; Christine O Menias; Malak Itani; Kristina A Butler; Dhakshinamoorthy Ganeshan
Journal:  Abdom Radiol (NY)       Date:  2021-06-05

Review 3.  Ovary: MRI characterisation and O-RADS MRI.

Authors:  Elizabeth A Sadowski; Katherine E Maturen; Andrea Rockall; Caroline Reinhold; Helen Addley; Priyanka Jha; Nishat Bharwani; Isabelle Thomassin-Naggara
Journal:  Br J Radiol       Date:  2021-04-30       Impact factor: 3.629

4.  Non-contrast MRI can accurately characterize adnexal masses: a retrospective study.

Authors:  Evis Sala; Helen Addley; Hilal Sahin; Camilla Panico; Stephan Ursprung; Vittorio Simeon; Paolo Chiodini; Amy Frary; Bruno Carmo; Janette Smith; Sue Freeman; Mercedes Jimenez-Linan; Helen Bolton; Krishnayan Haldar; Joo Ern Ang; Caroline Reinhold
Journal:  Eur Radiol       Date:  2021-03-16       Impact factor: 5.315

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.